You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Immunopathogenesis of Hidradenitis Suppurativa

  • Authors: James G. Krueger, MD, PhD
  • CPD Released: 5/9/2022
  • Valid for credit through: 5/9/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for a global audience of dermatologists, surgeons, primary care physicians, obstetricians & gynecologists, and emergency medicine physicians.

The goal of this activity is to highlight our current understanding of the immunopathogenesis of hidradenitis suppurativa (HS), its multifactorial etiology, and the role of the interleukin (IL)-17 pathway in the inflammatory process.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of genetics in the development of hidradenitis suppurativa (HS)
    • Multifactorial etiology of HS
    • Key inflammatory pathways in HS pathogenesis


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies. 


Faculty

  • James G. Krueger, MD, PhD

    D. Martin Carter Professor in Clinical Investigation
    Head of Laboratory for Investigative Dermatology
    Co-Director
    Center for Clinical and Translational Science
    The Rockefeller University Hospital
    New York City, New York, United States

    Disclosures

    Advisor or consultant for: AbbVie; Aclaris Therapeutics; Allergan Inc.; Almirall; Amgen; Arena Pharmaceuticals; Aristea Therapeutics Inc.; Asana BioSciences; BiogenIdec; BMS; Boehringer; Celgene; Escalier; Galapagos; Leo Pharma; Lilly; Menlo; Nimbus; Novartis; Pfizer; Sanofi; Sienna; Sun Pharma; USB; Valeant; Ventyx 
    Speaker or a member of a speakers bureau for: AbbVie; Akros; Allergan; Amgen; Avillion; Biogen MA; BMS; Boehringer; Botanix; Celgene; ExicureIncyte; Innovaderm; Janssen; Leo Pharma; Lilly; Nimbus; Novan; Novartis; Parexel; Pfizer; Regeneron; Sienna; UCB; Vitae

Editors

  • Alessia Piazza, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Disclosure: Alessia Piazza, PhD, has no relevant financial relationships.  

  • Diana Lucifero, PhD

    Scientific Content Manager, WebMD Global, LLC 

    Disclosures

    Disclosure: Diana Lucifero, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Immunopathogenesis of Hidradenitis Suppurativa

Authors: James G. Krueger, MD, PhDFaculty and Disclosures

CPD Released: 5/9/2022

Valid for credit through: 5/9/2023

processing....

Commentaire d'expert en français

Ce commentaire fait partie d’une activité de formation plus vaste. Après la participation, prière de retourner à  Immunopathogenesis of Hidradenitis Suppurativa  pour accéder à l’ensemble du contenu de formation relié. 

 
« Return to: Immunopathogenesis of Hidradenitis Suppurativa